{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:22:46Z","timestamp":1794856966201,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005765","name":"Universidade de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>To review the evidence regarding stroke and recent myocardial infarction (MI), reduced left ventricular ejection fraction, left ventricular thrombus (LVT), and wall motion abnormalities (WMA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>The risk of ischemic stroke associated with acute MI has been greatly reduced with reperfusion treatments that improved myocardium salvage. Acute ischemic stroke is an uncommon complication of diagnostic coronary angiography and percutaneous coronary intervention. For established LVT, anticoagulation is superior to antiplatelet medications to reduce the risk of ischemic stroke. The duration of anticoagulation should be at least 3 to 6\u00a0months. Direct oral anticoagulants have been used off-label in this context. In patients with low ejection fraction or WMA, there is no evidence that anticoagulation is superior to antiplatelet treatment in preventing ischemic stroke. In patients with ischemic stroke and recent MI (&lt;\u20093\u00a0months), type of MI (STEMI or NSTEMI), timing, and location should be considered when deciding whether intravenous thrombolysis should be used for stroke treatment. Mechanical thrombectomy should be considered as a therapeutic alternative to intravenous thrombolysis in patients with acute ischemic stroke due to large-vessel occlusion and recent MI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Most guidelines regarding prevention of ischemic stroke in patients with these cardiac causes of stroke are derived from expert opinion. There is a need for high quality evidence to support stroke prevention treatments in these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11886-023-02009-y","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T13:02:11Z","timestamp":1702299731000},"page":"1687-1697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Stroke and Recent Myocardial Infarction, Reduced Left Ventricular Ejection Fraction, Left Ventricular Thrombus, and Wall Motion Abnormalities"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6913-5526","authenticated-orcid":false,"given":"Ana Catarina","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"2009_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101537","volume":"48","author":"L Wang","year":"2023","unstructured":"Wang L, Chen Y, Shen W, Fan X, Jia M, Fu G, et al. A bibliometric analysis of cardioembolic stroke from 2012 to 2022. Curr Probl Cardiol. 2023;48:101537. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101537.","journal-title":"Curr Probl Cardiol"},{"issue":"Suppl 1","key":"2009_CR2","first-page":"S52","volume":"11","author":"MC Leary","year":"2008","unstructured":"Leary MC, Caplan LR. Cardioembolic stroke: An update on etiology, diagnosis and management. Ann Indian Acad Neurol. 2008;11(Suppl 1):S52\u201363.","journal-title":"Ann Indian Acad Neurol"},{"key":"2009_CR3","doi-asserted-by":"publisher","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35\u201341.\u00a0https:\/\/doi.org\/10.1161\/01.str.24.1.35.","DOI":"10.1161\/01.str.24.1.35"},{"key":"2009_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","volume":"366","author":"S Homma","year":"2012","unstructured":"Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366:1859\u201369.","journal-title":"N Engl J Med"},{"key":"2009_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02158-8","author":"LA Boivin-Proulx","year":"2023","unstructured":"Boivin-Proulx LA, Ieroncig F, Demers SP, Nozza A, Soltani M, Ghersi I, et al. Contemporary incidence and predictors of left ventricular thrombus in patients with anterior acute myocardial infarction. Clin Res Cardiol. 2023. https:\/\/doi.org\/10.1007\/s00392-023-02158-8.","journal-title":"Clin Res Cardiol"},{"key":"2009_CR6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jacc.2022.01.011","volume":"79","author":"A Camaj","year":"2022","unstructured":"Camaj A, Fuster V, Giustino G, Bienstock SW, Sternheim D, Mehran R, et al. Left ventricular thrombus following acute myocardial infarction: JACCstate-of-the-art review. J Am Coll Cardiol. 2022;79:1010\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2022.01.011.","journal-title":"J Am Coll Cardiol"},{"key":"2009_CR7","doi-asserted-by":"crossref","unstructured":"Aggarwal G, Patlolla SH, Aggarwal S, Cheungpasitporn W, Doshi R, Sundaragiri PR, et al. Temporal trends, predictors, and outcomes of acute ischemic stroke in acute myocardial infarction in the United States. J Am Heart Assoc. 2021;10:e017693.","DOI":"10.1161\/JAHA.120.017693"},{"key":"2009_CR8","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, et al; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022;146:e205-e223. Guidelines regarding management of patients with left ventricular thrombi.","DOI":"10.1161\/CIR.0000000000001092"},{"key":"2009_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s42466-022-00227-3","volume":"4","author":"S Kitmeridou","year":"2022","unstructured":"Kitmeridou S, Tsiptsios D, Tsalkidis D, Psatha EA, Iliopoulos I, Aggelousis N, et al. Intravenous thrombolysis for acute ischemic stroke associated with known left ventricular thrombus: safe or not? Neurol Res Pract. 2022;4:61. https:\/\/doi.org\/10.1186\/s42466-022-00227-3.","journal-title":"Neurol Res Pract"},{"key":"2009_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07417-w","author":"LAF Di Odoardo","year":"2022","unstructured":"Di Odoardo LAF, Bianco M, Gil IJN, Motolese IG, Chinaglia A, Vicenzi M, et al. Left ventricular thrombus management after acute myocardial infarction in clinical practice: results from LEVITATION survey and narrative review. Cardiovasc Drugs Ther. 2022. https:\/\/doi.org\/10.1007\/s10557-022-07417-w.","journal-title":"Cardiovasc Drugs Ther"},{"key":"2009_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0735-1097(03)81966-","volume":"41","author":"JS Gottdiener","year":"2003","unstructured":"Gottdiener JS, Massie B, Ammons SB, et al. Prevalence of left ventricular thrombus in dilated cardiomyopathy: the WATCH trial. J Am J Cardiol. 2003;41:202. https:\/\/doi.org\/10.1016\/S0735-1097(03)81966-.","journal-title":"J Am J Cardiol"},{"issue":"2","key":"2009_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7326\/0003-4819-122-2-199501150-00003","volume":"122","author":"E Sigurdsson","year":"1995","unstructured":"Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study Ann Intern Med. 1995;122(2):96\u2013102. https:\/\/doi.org\/10.7326\/0003-4819-122-2-199501150-00003. PMID: 7993002.","journal-title":"The Reykjavik Study Ann Intern Med"},{"key":"2009_CR13","doi-asserted-by":"crossref","unstructured":"Kamran S, Akhtar N, Singh R, Imam Y, Haroon KH, Amir N, et al. Association of major adverse cardiovascular events in patients with stroke and cardiac wall motion abnormalities. J Am Heart Assoc. 2021;10:e020888.","DOI":"10.1161\/JAHA.121.020888"},{"key":"2009_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00392-021-01930-y","volume":"111","author":"A Sch\u00e4fer","year":"2022","unstructured":"Sch\u00e4fer A, Flierl U, Bauersachs J. Anticoagulants for stroke prevention in heart failure with reduced ejection fraction. Clin Res Cardiol. 2022;111:1\u201313. https:\/\/doi.org\/10.1007\/s00392-021-01930-y.","journal-title":"Clin Res Cardiol"},{"key":"2009_CR15","unstructured":"Inpatient prevention and management of complications following stroke. Canadian Stroke Best Practices. Accessed October 30, 2023. https:\/\/www.strokebestpractices.ca\/en\/recommendations\/acute-stroke-management\/inpatient-prevention-and-management-of-complications-following-stroke\/."},{"key":"2009_CR16","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013418. https:\/\/doi.org\/10.1161\/STR.0000000000000211.","journal-title":"Stroke"},{"key":"2009_CR17","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a Guideline From The American Heart Association\/American Stroke Association. Stroke. 2021;52:e364\u2013467.","journal-title":"Stroke"},{"key":"2009_CR18","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00415-020-10393-6","volume":"268","author":"AC Fonseca","year":"2021","unstructured":"Fonseca AC, Ferro JM, Almeida AG. Cardiovascular magnetic resonance imaging and its role in the investigation of stroke: an update. J Neurol. 2021;268:2597\u2013604. https:\/\/doi.org\/10.1007\/s00415-020-10393-6.","journal-title":"J Neurol"},{"key":"2009_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/jcm12030840","volume":"12","author":"T Murakami","year":"2023","unstructured":"Murakami T, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, et al. Acute ischemic stroke and transient ischemic attack in ST-segment elevation myocardial infarction patients who underwent primary percutaneous coronary intervention. J Clin Med. 2023;12:840.","journal-title":"J Clin Med"},{"key":"2009_CR20","doi-asserted-by":"crossref","unstructured":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists\u2019 (FTT) Collaborative Group. Lancet. 1994;343:311\u201322. Erratum in: Lancet 1994 Mar 19;343(8899):742.","DOI":"10.1016\/S0140-6736(94)91161-4"},{"issue":"15","key":"2009_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jcin.2019.04.015","volume":"12","author":"M Alkhouli","year":"2019","unstructured":"Alkhouli M, Alqahtani F, Tarabishy A, Sandhu G, Rihal CS. Incidence, predictors, and outcomes of acute ischemic stroke following percutaneous coronary intervention. JACC Cardiovasc Interv. 2019;12(15):1497\u2013506. https:\/\/doi.org\/10.1016\/j.jcin.2019.04.015. PMID: 31395220.","journal-title":"JACC Cardiovasc Interv"},{"key":"2009_CR22","doi-asserted-by":"publisher","unstructured":"Korn-Lubetzki I, Farkash R, Pachino RM, et al. Incidence and risk factors of cerebrovascular events following cardiac catheterization. J Am Heart Assoc. 2013;2(6):e000413. https:\/\/doi.org\/10.1161\/JAHA.113.000413,indexedinPubmed:24231658.","DOI":"10.1161\/JAHA.113.000413,indexedinPubmed:24231658"},{"issue":"6","key":"2009_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/archneur.63.6.817","volume":"63","author":"P Khatri","year":"2006","unstructured":"Khatri P, Kasner SE. Ischemic strokes after cardiac catheterization: opportune thrombolysis candidates? Arch Neurol. 2006;63(6):817\u201321. https:\/\/doi.org\/10.1001\/archneur.63.6.817.","journal-title":"Arch Neurol"},{"issue":"10","key":"2009_CR24","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.33963\/KP.a2021.0100","volume":"79","author":"B Staszczak","year":"2021","unstructured":"Staszczak B, Malinowski KP, Wa\u0144ha W, Siudak Z, J\u0119drychowska M, Susu\u0142 M, Surowiec S, Darocha S, Surdacki A, Kurzyna M, Wojakowski W, Legutko J, Bartu\u015b K, Bartu\u015b S, Januszek R. Frequency and predictors of diagnostic coronary angiography and percutaneous coronary intervention related to stroke. Kardiol Pol. 2021;79(10):1099\u2013106. https:\/\/doi.org\/10.33963\/KP.a2021.0100.","journal-title":"Kardiol Pol"},{"issue":"3","key":"2009_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/0735-1097(95)00526-9","volume":"27","author":"M Khatibzadeh","year":"1996","unstructured":"Khatibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol. 1996;27(3):664\u20139. https:\/\/doi.org\/10.1016\/0735-1097(95)00526-9.","journal-title":"J Am Coll Cardiol"},{"key":"2009_CR26","doi-asserted-by":"crossref","unstructured":"French Study of Aortic Plaques in Stroke Group, P. Amarenco, A. Cohen, et al. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 334(1996);1216\u20131221","DOI":"10.1056\/NEJM199605093341902"},{"key":"2009_CR27","doi-asserted-by":"publisher","unstructured":"Jolly SS, Cairns JA, Yusuf S, Meeks B, Gao P, Hart RG, et al. TOTAL Investigators. Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. Eur Heart J. 2015;36:2364\u201372.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehv296.","DOI":"10.1093\/eurheartj\/ehv296"},{"key":"2009_CR28","doi-asserted-by":"crossref","unstructured":"Jolly SS, James S, Dzavik V, Cairns JA, Mahmoud KD, Zijlstra F, et al. Thrombus aspiration in ST-segment-elevation myocardial infarction. An individual patient meta-analysis: Thrombectomy Trialists Collaboration. Circulation 2017;135:143\u2013152.","DOI":"10.1161\/CIRCULATIONAHA.116.025371"},{"key":"2009_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"\u2022\u2022 Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.\u00a0ESC guidelines regarding management of patients with STEMI.","journal-title":"Eur Heart J"},{"key":"2009_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6951","volume":"11","author":"R Shiomura","year":"2023","unstructured":"Shiomura R, Miyachi H, Yamamoto T, Takano H. A rare mechanism of embolic stroke complicating coronary thrombus aspiration. Clin Case Rep. 2023;11:e6951. https:\/\/doi.org\/10.1002\/ccr3.6951.","journal-title":"Clin Case Rep"},{"key":"2009_CR31","doi-asserted-by":"publisher","unstructured":"Letsou GV, Musfee FI, Zhang Q, Loor G, Lee AD. Stroke and mortality rates after off-pump vs. pump-assisted\/no-clamp coronary artery bypass grafting. J Cardiovasc Surg (Torino). 2022;63:742\u2013748. https:\/\/doi.org\/10.23736\/S0021-9509.22.12337-2.","DOI":"10.23736\/S0021-9509.22.12337-2"},{"key":"2009_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/0735-1097(93)90409-T","volume":"22","author":"PT Vaitkus","year":"1993","unstructured":"Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22:1004\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2009_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1148\/radiol.2017161898","volume":"284","author":"E Cambronero-Cortinas","year":"2017","unstructured":"Cambronero-Cortinas E, Bonanad C, Monmeneu JV, Lopez-Lereu MP, Gavara J, de Dios E, et al. Incidence, outcomes, and predictors of ventricular thrombus after reperfused ST-segment-elevation myocardial infarction by using sequential cardiac MR imaging. Radiology. 2017;284:372\u201380.","journal-title":"Radiology"},{"key":"2009_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11239-019-01829-6","volume":"48","author":"AS Leow","year":"2019","unstructured":"Leow AS, Sia CH, Tan BY, Kaur R, Yeo TC, Chan MY, Tay EL, Seet RC, Loh JP, Yeo LL. Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarction. J Thromb Thrombolysis. 2019;48:158\u201366.","journal-title":"J Thromb Thrombolysis"},{"key":"2009_CR35","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"M Writing Committee","year":"2022","unstructured":"Writing Committee M, Lawton JS, Tamis-Holland JE, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:e21\u2013129.","journal-title":"J Am Coll Cardiol"},{"key":"2009_CR36","first-page":"E826","volume":"34","author":"LA Boivin-Proulx","year":"2022","unstructured":"Boivin-Proulx LA, Demers SP, Ieroncig F, Nozza A, Soltani M, Alansari Y, et al. Oral anticoagulation for the prevention of thromboembolic events in patients with anterior ST-segment elevation myocardial infarction. J Invasive Cardiol. 2022;34:E826\u201335.","journal-title":"J Invasive Cardiol"},{"key":"2009_CR37","unstructured":"EMA prasugrel. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/efient-epar-product-information_en.pdf."},{"key":"2009_CR38","unstructured":"FDA prasugrel. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022307s002lbl.pdf."},{"key":"2009_CR39","unstructured":"FDA \u2013 ticagrelor. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/022433s020lbl.pdf."},{"key":"2009_CR40","unstructured":"EMA \u2013 ticagrelor. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/brilique-epar-product-information_en.pdf."},{"key":"2009_CR41","doi-asserted-by":"publisher","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007 Nov 15;357(20):2001\u201315.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa0706482.","DOI":"10.1056\/NEJMoa0706482"},{"key":"2009_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0002-8703(05)80084-5","volume":"119","author":"G Kouvaras","year":"1990","unstructured":"Kouvaras G, Chronopoulos G, Soufras G, Sofronas G, Solomos D, Bakirtzis A, et al. The effects of long-term antithrombotic treatment on left ventricular thrombi in patients after an acute myocardial infarction. Am Heart J. 1990;119:73\u20138.","journal-title":"Am Heart J"},{"key":"2009_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41569-021-00539-y.**AcomprehensivereviewofthecurrentdoubtsregardingmanagementofleftventricularthrombusinpatientswithSTEMI","volume":"18","author":"LAF Di Odoardo","year":"2021","unstructured":"\u2022\u2022 Di Odoardo LAF, Stefanini GG, Vicenzi M. Uncertainties about left ventricular thrombus after STEMI. Nat Rev Cardiol. 2021;18:381\u20132. https:\/\/doi.org\/10.1038\/s41569-021-00539-y.\u00a0A comprehensive review of the current doubts regarding management of left ventricular thrombus in patients with STEMI.","journal-title":"Nat Rev Cardiol"},{"key":"2009_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.21037\/atm-20-7839","volume":"9","author":"JB Cruz Rodriguez","year":"2021","unstructured":"Cruz Rodriguez JB, Okajima K, Greenberg BH. Management of left ventricular thrombus: a narrative review. Ann Transl Med. 2021;9:520. https:\/\/doi.org\/10.21037\/atm-20-7839.","journal-title":"Ann Transl Med"},{"key":"2009_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000001230","author":"CS Kwok","year":"2023","unstructured":"Kwok CS, Bennett S, Borovac JA, Will M, Schwarz K, Lip GYH. An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis. Coron Artery Dis. 2023. https:\/\/doi.org\/10.1097\/MCA.0000000000001230.","journal-title":"Coron Artery Dis"},{"key":"2009_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/ehjcvp\/pvaa066","volume":"7","author":"M Massussi","year":"2021","unstructured":"Massussi M, Scotti A, Lip GYH, Proietti R. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7:158\u201367. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa066.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2009_CR47","doi-asserted-by":"publisher","unstructured":"Cokkinos DV, Haralabopoulos GC, Kostis JB, Toutouzas PK. HELAS investigators. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study. Eur J Heart Fail. 2006;8:428\u201332.\u00a0https:\/\/doi.org\/10.1016\/j.ejheart.2006.02.012.","DOI":"10.1016\/j.ejheart.2006.02.012"},{"key":"2009_CR48","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","volume":"379","author":"F Zannad","year":"2018","unstructured":"Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med. 2018;379:1332\u201342.","journal-title":"N Engl J Med"},{"key":"2009_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","volume":"148","author":"JG Cleland","year":"2004","unstructured":"Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, et al. The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J. 2004;148:157\u201364. https:\/\/doi.org\/10.1016\/j.ahj.2004.03.010.","journal-title":"Am Heart J"},{"key":"2009_CR50","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","volume":"119","author":"BM Massie","year":"2009","unstructured":"Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009;119:1616\u201324. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.801753.","journal-title":"Circulation"},{"key":"2009_CR51","doi-asserted-by":"crossref","unstructured":"\u2022 Marto JP, Kauppila LA, Jorge C, Calado S, Viana-Baptista M, Pinho-E-Melo T, et al. Intravenous thrombolysis for acute ischemic stroke after recent myocardial infarction: case series and systematic review. Stroke. 2019;50:2813\u20132818. One of the largest case series of patients with acute MI treated with intravenous thrombolysis for acute ischemic stroke.","DOI":"10.1161\/STROKEAHA.119.025630"},{"key":"2009_CR52","doi-asserted-by":"crossref","unstructured":"Inohara T, Liang L, Kosinski AS, et al. Recent myocardial infarction is associated with increased risk in older adults with acute ischemic stroke receiving thrombolytic therapy. J Am Heart Assoc. 2019;8:e012450.","DOI":"10.1161\/JAHA.119.012450"},{"key":"2009_CR53","doi-asserted-by":"publisher","unstructured":"Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6:I-LXII.\u00a0https:\/\/doi.org\/10.1177\/2396987321989865.","DOI":"10.1177\/2396987321989865"},{"key":"2009_CR54","doi-asserted-by":"crossref","unstructured":"Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA 1995;274:1017\u20131025.","DOI":"10.1001\/jama.274.13.1017"},{"key":"2009_CR55","doi-asserted-by":"crossref","unstructured":"Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;35:1317\u20131329.","DOI":"10.1056\/NEJMoa0804656"},{"key":"2009_CR56","doi-asserted-by":"publisher","unstructured":"Marto JP, Kauppila LA, Jorge C, Faustino P, Sargento-Freitas J, Pereira L, et al. Acute myocardial infarction after intravenous thrombolysis for acute ischemic stroke: case series and systematic review. J Stroke Cerebrovasc Dis. 2022;31:106244. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.106244.","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106244"},{"key":"2009_CR57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3174\/ajnr.A4520","volume":"37","author":"F Dorn","year":"2016","unstructured":"Dorn F, Prothmann S, Patzig M, Lockau H, Kabbasch C, Nikoubashman O, et al. Stent retriever thrombectomy in patients who are ineligible for intravenous thrombolysis: a multicenter retrospective observational study. AJNR Am J Neuroradiol. 2016;37:305\u201310. https:\/\/doi.org\/10.3174\/ajnr.A4520.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2009_CR58","doi-asserted-by":"crossref","unstructured":"Alonso de Leci\u00f1ana M, Mart\u00ednez-S\u00e1nchez P, Garc\u00eda-Pastor A, Kawiorski MM, Calleja P, Sanz-Cuesta BE, et al. Mechanical thrombectomy in patients with medical contraindications for intravenous thrombolysis: a prospective observational study. J Neurointerv Surg. 2017;11:1041\u20131046.","DOI":"10.1136\/neurintsurg-2016-012727"},{"key":"2009_CR59","doi-asserted-by":"publisher","unstructured":"Turc G, Tsivgoulis G, Audebert HJ, Boogaarts H, Bhogal P, De Marchis GM, et al. J. European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large-vessel occlusion. J Neurointerv Surg. 2022;(3):209.\u00a0https:\/\/doi.org\/10.1136\/neurintsurg-2021-018589.","DOI":"10.1136\/neurintsurg-2021-018589"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-023-02009-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-023-02009-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-023-02009-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:49:28Z","timestamp":1706183368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-023-02009-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2009"],"URL":"https:\/\/doi.org\/10.1007\/s11886-023-02009-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"27 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}